dapsone has been researched along with IgA Vasculitis in 24 studies
IgA Vasculitis: A systemic non-thrombocytopenic purpura caused by HYPERSENSITIVITY VASCULITIS and deposition of IGA-containing IMMUNE COMPLEXES within the blood vessels throughout the body, including those in the kidney (KIDNEY GLOMERULUS). Clinical symptoms include URTICARIA; ERYTHEMA; ARTHRITIS; GASTROINTESTINAL HEMORRHAGE; and renal involvement. Most cases are seen in children after acute upper respiratory infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In chronic cutaneous manifestations of IgA vasculitis, dapsone seems to show a good effectiveness." | 9.01 | Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. ( Dima, B; Gilliaux, O; Muyshont, L; Roman, C; Schurmans, T, 2019) |
| " In chronic cutaneous manifestations of IgA vasculitis, dapsone seems to show a good effectiveness." | 5.01 | Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. ( Dima, B; Gilliaux, O; Muyshont, L; Roman, C; Schurmans, T, 2019) |
| "Dapsone therapy for leukocytoclastic (necrotizing) vasculitis has been little used, except for the variant forms of erythema elevatum diutinum and urticarial vasculitis." | 3.67 | Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. ( Fredenberg, MF; Malkinson, FD, 1987) |
| "Haemorrhagic bullous lesions are a recognized but rare occurrence with HSP in children." | 2.45 | Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus? ( Kausar, S; Yalamanchili, A, 2009) |
| "Dapsone was introduced when skin lesions were recurrent, extensive, and persistent, due to its known ability to act as an anti-IgA and as an anticytotoxic agent against polynuclear neutrophils." | 1.37 | [Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis]. ( Fischbach, M; Lipsker, D; Mazille, N, 2011) |
| "Dapsone is a sulfone essentially used to treat leprae." | 1.34 | [Dapsone: an opportunity to spare corticoid use for Henoch-Schönlein treatment? A case report]. ( Bovy, C; Krzesinski, JM; Parotte, MC, 2007) |
| " Therefore dapsone therapy was initiated at a dosage of 100 mg daily after checking the glucose-6-phosphate-dehydrogenase and with regular control of the blood methemoglobin level." | 1.30 | [Henoch-Schönlein purpura: successful treatment with Dapsone]. ( Abeck, D; Albrecht, J; Hein, R; Mempel, M; Ring, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.67) | 18.7374 |
| 1990's | 4 (16.67) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshida, M | 1 |
| Nambu, R | 1 |
| Yasuda, R | 1 |
| Sakaguchi, H | 1 |
| Hara, T | 1 |
| Iwama, I | 1 |
| Mizuochi, T | 1 |
| Ramelli, V | 1 |
| Rinoldi, PO | 1 |
| Bianchetti, MG | 2 |
| Lava, SAG | 1 |
| Ramelli, GP | 2 |
| Milani, GP | 1 |
| Lee, KH | 1 |
| Park, JH | 1 |
| Kim, DH | 1 |
| Hwang, J | 1 |
| Lee, G | 1 |
| Hyun, JS | 1 |
| Heo, ST | 1 |
| Choi, JH | 1 |
| Kim, M | 2 |
| Kim, SI | 1 |
| Eisenhut, M | 1 |
| Kronbichler, A | 1 |
| Shin, JI | 2 |
| Volejnikova, J | 1 |
| Horacek, J | 1 |
| Kopriva, F | 1 |
| Roman, C | 1 |
| Dima, B | 1 |
| Muyshont, L | 1 |
| Schurmans, T | 1 |
| Gilliaux, O | 1 |
| Bech, AP | 1 |
| Reichert, LJ | 1 |
| Cohen Tervaert, JW | 1 |
| Chen, CB | 1 |
| Garlapati, S | 1 |
| Lancaster, JD | 1 |
| Zinn, Z | 1 |
| Bacaj, P | 1 |
| Patra, KP | 1 |
| Kausar, S | 1 |
| Yalamanchili, A | 1 |
| Sakanoue, M | 1 |
| Higashi, Y | 1 |
| Kawai, K | 2 |
| Sugita, S | 1 |
| Kanekura, T | 1 |
| Mazille, N | 1 |
| Lipsker, D | 1 |
| Fischbach, M | 1 |
| Hirahara, K | 1 |
| Kano, Y | 1 |
| Asano, Y | 1 |
| Shiohara, T | 1 |
| Shimomura, N | 1 |
| Watanabe, S | 1 |
| Katsuumi, K | 1 |
| Ito, M | 1 |
| Iqbal, H | 1 |
| Evans, A | 1 |
| Lee, JS | 1 |
| Chung, KS | 1 |
| Parotte, MC | 1 |
| Bovy, C | 1 |
| Krzesinski, JM | 1 |
| Ledermann, JA | 1 |
| Hoffbrand, BI | 2 |
| Sarma, PS | 1 |
| Albrecht, J | 1 |
| Mempel, M | 1 |
| Hein, R | 1 |
| Abeck, D | 1 |
| Ring, J | 1 |
| Saulsbury, FT | 1 |
| Hart, MH | 1 |
| Vesole, DH | 1 |
| Chamouard, P | 1 |
| Baumann, R | 1 |
| Thomas, G | 1 |
| Weill, JP | 1 |
| Fredenberg, MF | 1 |
| Malkinson, FD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neuroprotective Effect of Dapsone in Patients With Aneurysmal Subarachnoid Hemorrhage: Prospective, Randomized, Double-Blinded, Placebo-Controlled, Clinical Trial[NCT05131295] | Phase 3 | 49 participants (Actual) | Interventional | 2007-09-05 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dapsone and IgA Vasculitis
| Article | Year |
|---|---|
Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature.
Topics: Child, Preschool; Chronic Disease; Dapsone; Female; Folic Acid Antagonists; Humans; IgA Vasculitis; | 2019 |
Management of haemorrhagic bullous lesions in Henoch-Schonlein purpura: is there any consensus?
Topics: Adrenal Cortex Hormones; Blister; Child; Combined Modality Therapy; Dapsone; Disease Progression; Dr | 2009 |
22 other studies available for dapsone and IgA Vasculitis
| Article | Year |
|---|---|
Dapsone for Refractory Gastrointestinal Symptoms in Children With Immunoglobulin A Vasculitis.
Topics: Abdominal Pain; Adrenal Cortex Hormones; Child; Dapsone; Gastrointestinal Diseases; Humans; IgA Vasc | 2022 |
Dapsone in immunoglobulin A-associated vasculitis.
Topics: Dapsone; Humans; IgA Vasculitis; Immunoglobulin A; Vasculitis; Vasculitis, Leukocytoclastic, Cutaneo | 2019 |
Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP).
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Chemotaxis; Cytokines; Dapsone; Free Radicals; Hu | 2017 |
Dapsone treatment is efficient against persistent cutaneous and gastrointestinal symptoms in children with Henoch-Schönlein purpura.
Topics: Adolescent; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Dapsone; Ga | 2018 |
Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein).
Topics: Anti-Infective Agents; Biopsy; Dapsone; Diagnosis, Differential; Female; Humans; IgA Vasculitis; Ski | 2013 |
Bullous Henoch-Schönlein purpura in children.
Topics: Abdominal Pain; Adolescent; Dapsone; Dermatologic Agents; Female; Follow-Up Studies; Glucocorticoids | 2015 |
Henoch-Schönlein purpura with epididymitis in an adult.
Topics: Adult; Dapsone; Epididymitis; Humans; IgA Vasculitis; Male; Prednisolone | 2011 |
[Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis].
Topics: Adolescent; Dapsone; Female; Humans; IgA Vasculitis; Male; Skin Diseases | 2011 |
Osteonecrosis of the femoral head in a patient with Henoch-Schönlein purpura and drug-induced hypersensitivity syndrome treated with corticosteroids.
Topics: Adult; Anti-Infective Agents; Dapsone; Eosinophilia; Erythema; Exanthema; Femur Head Necrosis; Fever | 2013 |
Adult Henoch-Schönlein purpura with severe abdominal pain treated with dapsone and factor XIII concentrate.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Diagnosis, Differential; Dr | 2005 |
Dapsone therapy for Henoch-Schönlein purpura: a case series.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dapsone; Female; Humans; IgA Vascu | 2005 |
Dapsone therapy for Henoch-Schonlein purpura.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Child; Child, Preschool; Dapsone; Female; Humans; IgA Vascu | 2006 |
[Dapsone: an opportunity to spare corticoid use for Henoch-Schönlein treatment? A case report].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Dapsone; Drug Resistance; Drug Therapy, Co | 2007 |
Dapsone in allergic vasculitis: its use in Henoch-Schönlein disease following vaccination.
Topics: Adult; Chronic Disease; Dapsone; Humans; IgA Vasculitis; Male; Vaccination; Vasculitis, Leukocytocla | 1983 |
Dapsone in Henoch-Schönlein purpura.
Topics: Adolescent; Adult; Dapsone; Drug Administration Schedule; Female; Humans; IgA Vasculitis; Male; Midd | 1994 |
Dapsone in cutaneous Henoch-Schönlein syndrome--worth a trial.
Topics: Adolescent; Dapsone; Dose-Response Relationship, Drug; Female; Humans; IgA Vasculitis; Leprostatic A | 1997 |
[Henoch-Schönlein purpura: successful treatment with Dapsone].
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dapsone; Follow-Up Studies; Humans; IgA Vasculitis; | 1999 |
Crohn's disease presenting with Henoch-Schönlein purpura.
Topics: Adolescent; Biopsy; Blood Vessels; Colon; Complement C3; Crohn Disease; Dapsone; Endoscopy, Gastroin | 2000 |
Dapsone in Henoch-Schönlein purpura--worth a trial.
Topics: Adolescent; Adult; Aged; Dapsone; Humans; IgA Vasculitis; Male; Neutrophils | 1991 |
Diffuse large-cell lymphoma in an adult with Schönlein-Henoch purpura.
Topics: Chronic Disease; Dapsone; Humans; IgA Vasculitis; Immunoglobulin lambda-Chains; Immunoglobulin M; Ly | 1987 |
[Value of dapsone in the treatment of digestive manifestations of rheumatoid purpura in adults].
Topics: Aged; Dapsone; Humans; IgA Vasculitis; Intestinal Diseases; Male; Stomach Diseases | 1987 |
Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases.
Topics: Adolescent; Blood Vessels; Dapsone; Female; Humans; IgA Vasculitis; Middle Aged; Skin; Vasculitis | 1987 |